Item Text

29. PROOF OF CLAIM FOR INCLUSION IN THE SETTLEMENT REGARDING DDAVP INDIRECT PURCHASER ANTITRUST LITIGATION Approve the Proof of Claim submitted by Maricopa County for inclusion in the settlement of a certified class action filed by other entities for reimbursement of overpayments made for certain brand-name prescription drugs. Authorize compromise of the claim in the amount of $285.31. This request concerns the lawsuit entitled DDAVP INDIRECT PURCHASER ANTITRUST LITIGATION. Civil Action No. 05–CV–2237 Multiple employee welfare benefit plans brought this antitrust action alleging, among other things, that prescription drug manufacturers Ferring B.V. and FerringPharmaceuticals, Inc. (“Ferring”) and Aventis Pharmaceuticals, Inc. (“Aventis”) engaged in a course of conduct to delay the sale of generic versions of DDAVP tablets. The lawsuit claims this conduct violated federal and state antitrust laws and consumer protection laws by delaying the entry into the market of low-cost generic versions of DDAVP tablets. Ferring and Aventis paid $4.75 million into a Settlement Fund. Maricopa County filed a Proof of Claim on January 14, 2014. The class settlement provides for payment of Maricopa County’s claim in the amount of $285.31. The Board is requested to approve the Proof of Claim submitted and authorize the compromise of the claim in the amount of $285.31. (C-39-15-022-S-00)